62．Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi, Comment on: ‘Detecting drug-drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system’ by Matsuo et al, Journal of Clinical Pharmacy and Therapeutics, 47, 709-710, 2022.．

63．Yoshihiro Noguchi, Comment on : "Drug–Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data," Drug Saf., 45, 809–811, https://doi.org/10.1007/s40264-022-01191-2, 2022.

64．Yoshihiro Noguchi, Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)," Drug Saf., 45, 1551–1552, https://doi.org/10.1007/s40264-022-01240-w, 2022.